Difficulty: Medium
Average Score: 66%
Practice
Of the following, the WORST prognostic factor in pediatric osteosarcoma is
Correct answer
B
Rationale
In pediatric osteosarcoma, the worst prognostic factor among the options given is poor histologic response to treatment (Option B). This is because a poor response to treatment indicates that the tumor is more aggressive and less likely to be effectively controlled or eradicated. A good histologic response is associated with better outcomes, including higher rates of survival and lower risk of recurrence.
Option A (primary pelvic bone tumor) is not as poor a prognostic factor as poor histologic response because the primary tumor's location alone does not necessarily dictate the response to treatment or overall prognosis. Osteosarcoma can occur in various bones, and while pelvic tumors may present challenges due to the proximity to vital structures, they are not inherently associated with worse outcomes.
Option C (bony metastases at the time of diagnosis) is also a serious factor but not as detrimental as a poor histologic response. Metastases indicate disease spread, which can complicate treatment, but response to therapy still plays a significant role in determining outcomes.
Option D (lung metastases at the time of diagnosis) is a negative prognostic factor but is not as critical as poor histologic response. Lung metastases are common in osteosarcoma and can impact prognosis, but the response to treatment remains a crucial determinant of overall success.
Educationally, understanding prognostic factors in pediatric osteosarcoma is vital for nurses caring for pediatric oncology patients. Recognizing the significance of histologic response can guide nursing assessments, interventions, and patient education efforts. Nurses play a key role in monitoring treatment responses, managing side effects, and supporting patients and families through the challenges of osteosarcoma treatment.
Option A (primary pelvic bone tumor) is not as poor a prognostic factor as poor histologic response because the primary tumor's location alone does not necessarily dictate the response to treatment or overall prognosis. Osteosarcoma can occur in various bones, and while pelvic tumors may present challenges due to the proximity to vital structures, they are not inherently associated with worse outcomes.
Option C (bony metastases at the time of diagnosis) is also a serious factor but not as detrimental as a poor histologic response. Metastases indicate disease spread, which can complicate treatment, but response to therapy still plays a significant role in determining outcomes.
Option D (lung metastases at the time of diagnosis) is a negative prognostic factor but is not as critical as poor histologic response. Lung metastases are common in osteosarcoma and can impact prognosis, but the response to treatment remains a crucial determinant of overall success.
Educationally, understanding prognostic factors in pediatric osteosarcoma is vital for nurses caring for pediatric oncology patients. Recognizing the significance of histologic response can guide nursing assessments, interventions, and patient education efforts. Nurses play a key role in monitoring treatment responses, managing side effects, and supporting patients and families through the challenges of osteosarcoma treatment.